A new and independent report
by McKinsey & Company has estimated the benefits
- in lives and value - of implementing one single global standard in Healthcare
The McKinsey & Company report, voicing the view of 80 thought leaders in the Healthcare industry, highlights the need to align on a single global standard to ensure patient safety and explains the urgency of driving adoption across all supply chain stakeholders.
Key highlights are as follows:
- The research has revealed "that implementing global standards across the entire healthcare supply chain could save 22-43,000 lives and avert 0.7 to 1.4 million patient disabilities."
- Addressing counterfeit drugs, a major and ever growing problem for public health and industry, the report concludes that "rolling-out standards based systems could prevent tens of billions of dollars’ worth of counterfeit drugs from entering the legitimate supply chain."
- At the same time, it states that "global standards could enable substantial safety benefits and enable healthcare cost reduction of $40-100 billion". Once adopted, global standards benefits will span over all the supply chain stakeholders from manufacturers to patients.
- "The healthcare industry faces a potentially costly patchwork of requirements. Over the long term this patchwork could become unworkable. The adoption of a single set of global standards will cost significantly less than two and far less than three or more".
McKinsey reports in your language:
- McKinsey report in English: "Strength in unity: The promise of global standards in healthcare"
- McKinsey report in French: 'L'union fait la force: Les bénéfices d’un standard mondial pour les soins de santé"
- McKinsey report in Portugese: "Força na unidade: A promessa de padrões globais no setor de saúde"
- McKinsey report in Spanish: "Fortaleza en la unidad: La promesa de los estándores globales en salud"
McKinsey Collaterals and press release